TADROS RAMY
SEC CIK 1714199 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MET | MetLife | Pres, U.S. Business | 212.7K | — | $289.5K | 19 | 2022-02-22 | 2026-09-08 |
Most active insiders at MET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DEBEL MARLENE | EVP, CRO | — | $1.74M |
| 2 | O'Neill Adrienne Karen | EVP, CAO | — | — |
| 3 | Mumenthaler Christian Stephane | Dir | — | — |
| 4 | Curtis Monica M | EVP, CLO | — | — |
| 5 | Sibblies Shurawl | EVP, Chief HR Off | — | — |
| 6 | Hay Laura J | Dir | — | — |
| 7 | Seitz Michelle | Dir | — | — |
| 8 | PAPPAS BILL | EVP, Gbl Tech, Ops | — | — |
| 9 | WEINBERGER MARK A | Dir | — | — |
| 10 | MCKENZIE DIANA | Dir | — | — |
| 11 | TADROS RAMY | Pres, U.S. Business | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:02 | 2026-09-08 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | $95.50 | +115 | 212.7K | +0.1% | +$11.0K | |
| 2026-09-02 16:18 | 2026-08-31 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $95.17 | -4,366 | 212.6K | -2% | -$415.5K | |
| 2026-06-11 16:02 | 2026-06-09 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | $85.57 | +127 | 216.9K | +0.1% | +$10.9K | |
| 2026-03-04 | 2026-03-02 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $73.24 | -5,166 | 216.8K | -2% | -$378.4K | |
| 2026-02-26 | 2026-02-24 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $75.34 | -2,299 | 222.0K | -1% | -$173.2K | |
| M | 2026-02-26 | 2026-02-24 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +42.9K | 224.3K | +24% | — |
| 2025-03-05 | 2025-03-03 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $85.70 | -4,863 | 181.4K | -3% | -$416.8K | |
| M | 2025-02-27 | 2025-02-25 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +62.3K | 164.3K | +61% | — |
| 2025-02-27 | 2025-02-25 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $82.20 | -23.0K | 186.2K | -11% | -$1.89M | |
| 2024-03-14 | 2024-03-13 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | S - Sale | $71.90 | -4,026 | 147.0K | -3% | -$289.5K | |
| 2024-03-05 | 2024-03-01 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $69.73 | -4,821 | 151.0K | -3% | -$336.2K | |
| DM | 2024-02-29 | 2024-02-27 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +72.3K | 188.5K | +62% | — |
| D | 2024-02-29 | 2024-02-27 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $69.16 | -32.6K | 155.8K | -17% | -$2.26M |
| 2023-09-05 | 2023-08-31 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +7,894 | 116.2K | +7% | — | |
| DM | 2023-03-02 | 2023-02-28+ | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $71.67 | -41.0K | 113.3K | -27% | -$2.94M |
| DM | 2023-03-02 | 2023-02-28 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +77.6K | 149.3K | +108% | — |
| 2022-03-03 | 2022-03-01 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $64.44 | -4,668 | 71.8K | -6% | -$300.8K | |
| D | 2022-02-24 | 2022-02-22 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | F - Tax | $68.96 | -22.3K | 76.4K | -23% | -$1.54M |
| DM | 2022-02-24 | 2022-02-22 | MET | MetLife | TADROS RAMY | Pres, U.S. Business | A - Grant | — | +52.7K | 98.8K | +115% | — |
Purchase Sale Sale after option exercise All abbreviations